Header Logo

Connection

Peter Konrad to Parkinson Disease

Back to Details
This is a "connection" page, showing publications Peter Konrad has written about Parkinson Disease.
Peter Konrad
Connection Strength
4.961
Parkinson Disease
  1. Author Response: Deep Brain Stimulation in Early-Stage Parkinson Disease: Five-Year Outcomes. Neurology. 2021 Mar 23; 96(12):591.
    View in: PubMed
    Score: 0.636
  2. Pilot study assessing the feasibility of applying bilateral subthalamic nucleus deep brain stimulation in very early stage Parkinson's disease: study design and rationale. J Parkinsons Dis. 2012; 2(3):215-23.
    View in: PubMed
    Score: 0.336
  3. Deep brain stimulation in early stage Parkinson's disease: operative experience from a prospective randomised clinical trial. J Neurol Neurosurg Psychiatry. 2012 Feb; 83(2):164-70.
    View in: PubMed
    Score: 0.328
  4. Subthalamic nucleus neuronal firing rate increases with Parkinson's disease progression. Mov Disord. 2011 Aug 01; 26(9):1657-62.
    View in: PubMed
    Score: 0.320
  5. Electrode position and cognitive outcome following deep brain stimulation surgery. J Neurosurg. 2024 Jul 01; 141(1):230-240.
    View in: PubMed
    Score: 0.194
  6. Intraoperative physiology augments atlas-based data in awake deep brain stimulation. J Neurol Neurosurg Psychiatry. 2023 Dec 14; 95(1):86-96.
    View in: PubMed
    Score: 0.192
  7. Structural brain differences in essential tremor and Parkinson's disease deep brain stimulation patients. J Clin Neurosci. 2023 Sep; 115:121-128.
    View in: PubMed
    Score: 0.187
  8. Long-term neuropsychological outcomes of deep brain stimulation in early-stage Parkinson's disease. Parkinsonism Relat Disord. 2023 Aug; 113:105479.
    View in: PubMed
    Score: 0.186
  9. Connectivity Profile for Subthalamic Nucleus Deep Brain Stimulation in Early Stage Parkinson Disease. Ann Neurol. 2023 Aug; 94(2):271-284.
    View in: PubMed
    Score: 0.185
  10. Eleven-Year Outcomes of Deep Brain Stimulation in Early-Stage Parkinson Disease. Neuromodulation. 2023 Feb; 26(2):451-458.
    View in: PubMed
    Score: 0.180
  11. BDNF rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's Disease. Neuromodulation. 2022 Aug; 25(6):846-853.
    View in: PubMed
    Score: 0.173
  12. Early subthalamic nucleus deep brain stimulation in Parkinson's disease reduces long-term medication costs. Clin Neurol Neurosurg. 2021 Nov; 210:106976.
    View in: PubMed
    Score: 0.165
  13. Author Response: Deep Brain Stimulation in Early-Stage Parkinson Disease: Five-Year Outcomes. Neurology. 2021 Mar 23; 96(12):592.
    View in: PubMed
    Score: 0.159
  14. Deep brain stimulation in early-stage Parkinson disease: Five-year outcomes. Neurology. 2020 Jul 28; 95(4):e393-e401.
    View in: PubMed
    Score: 0.151
  15. Structural Correlates of the Sensorimotor Cerebellum in Parkinson's Disease and Essential Tremor. Mov Disord. 2020 Jul; 35(7):1181-1188.
    View in: PubMed
    Score: 0.149
  16. White matter differences between essential tremor and Parkinson disease. Neurology. 2019 Jan 01; 92(1):e30-e39.
    View in: PubMed
    Score: 0.135
  17. Effects of deep brain stimulation on rest tremor progression in early stage Parkinson disease. Neurology. 2018 Jul 31; 91(5):e463-e471.
    View in: PubMed
    Score: 0.132
  18. The Effects of Dexmedetomidine on Microelectrode Recordings of the Subthalamic Nucleus during Deep Brain Stimulation Surgery: A Retrospective Analysis. Stereotact Funct Neurosurg. 2017; 95(1):40-48.
    View in: PubMed
    Score: 0.119
  19. Subthalamic Nucleus Deep Brain Stimulation Alters Prefrontal Correlates of Emotion Induction. Neuromodulation. 2017 Apr; 20(3):233-237.
    View in: PubMed
    Score: 0.117
  20. Deep brain stimulation of the subthalamic nucleus alters frontal activity during spatial working memory maintenance of patients with Parkinson's disease. Neurocase. 2016 Aug; 22(4):369-78.
    View in: PubMed
    Score: 0.114
  21. Subthalamic Nucleus Deep Brain Stimulation May Reduce Medication Costs in Early Stage Parkinson's Disease. J Parkinsons Dis. 2016; 6(1):125-31.
    View in: PubMed
    Score: 0.111
  22. Deep brain stimulation may reduce the relative risk of clinically important worsening in early stage Parkinson's disease. Parkinsonism Relat Disord. 2015 Oct; 21(10):1177-83.
    View in: PubMed
    Score: 0.108
  23. Neuropsychological effects of deep brain stimulation in subjects with early stage Parkinson's disease in a randomized clinical trial. J Parkinsons Dis. 2015; 5(1):151-63.
    View in: PubMed
    Score: 0.103
  24. Deep brain stimulation in early stage Parkinson's disease. Parkinsonism Relat Disord. 2015 Mar; 21(3):347-8.
    View in: PubMed
    Score: 0.103
  25. Subthalamic nucleus deep brain stimulation in early stage Parkinson's disease. Parkinsonism Relat Disord. 2014 Jul; 20(7):731-7.
    View in: PubMed
    Score: 0.098
  26. Ventricular width and complicated recovery following deep brain stimulation surgery. Stereotact Funct Neurosurg. 2012; 90(3):167-72.
    View in: PubMed
    Score: 0.086
  27. Potential subjects' responses to an ethics questionnaire in a phase I study of deep brain stimulation in early Parkinson's disease. J Clin Ethics. 2012; 23(3):207-16.
    View in: PubMed
    Score: 0.084
  28. Deep brain stimulation for early-stage Parkinson's disease: an illustrative case. Neuromodulation. 2011; 14(6):515-21; discussion 521-2.
    View in: PubMed
    Score: 0.082
  29. Fully automated targeting using nonrigid image registration matches accuracy and exceeds precision of best manual approaches to subthalamic deep brain stimulation targeting in Parkinson disease. Neurosurgery. 2015 Jun; 76(6):756-65.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.